ARTL
Price
$4.60
Change
+$0.25 (+5.75%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
11.26M
LSTA
Price
$2.19
Change
+$0.08 (+3.79%)
Updated
Sep 5, 04:51 PM (EDT)
Capitalization
18.14M
62 days until earnings call
Interact to see
Advertisement

ARTL vs LSTA

Header iconARTL vs LSTA Comparison
Open Charts ARTL vs LSTABanner chart's image
Artelo Biosciences
Price$4.60
Change+$0.25 (+5.75%)
Volume$4.27K
Capitalization11.26M
Lisata Therapeutics
Price$2.19
Change+$0.08 (+3.79%)
Volume$500
Capitalization18.14M
ARTL vs LSTA Comparison Chart in %
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTL vs. LSTA commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Hold and LSTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (ARTL: $4.35 vs. LSTA: $2.11)
Brand notoriety: ARTL and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 173% vs. LSTA: 82%
Market capitalization -- ARTL: $11.26M vs. LSTA: $18.14M
ARTL [@Biotechnology] is valued at $11.26M. LSTA’s [@Biotechnology] market capitalization is $18.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 0 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • ARTL’s FA Score: 0 green, 5 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTL is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 4 TA indicator(s) are bullish while LSTA’s TA Score has 4 bullish TA indicator(s).

  • ARTL’s TA Score: 4 bullish, 6 bearish.
  • LSTA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ARTL and LSTA are a bad buy in the short-term.

Price Growth

ARTL (@Biotechnology) experienced а -51.88% price change this week, while LSTA (@Biotechnology) price change was -10.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

LSTA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSTA($18.1M) has a higher market cap than ARTL($11.3M). LSTA YTD gains are higher at: -29.195 vs. ARTL (-31.604). ARTL has higher annual earnings (EBITDA): -10.71M vs. LSTA (-20.83M). LSTA has more cash in the bank: 22M vs. ARTL (2.07M). LSTA has less debt than ARTL: LSTA (47K) vs ARTL (878K). LSTA has higher revenues than ARTL: LSTA (1.07M) vs ARTL (0).
ARTLLSTAARTL / LSTA
Capitalization11.3M18.1M62%
EBITDA-10.71M-20.83M51%
Gain YTD-31.604-29.195108%
P/E RatioN/AN/A-
Revenue01.07M-
Total Cash2.07M22M9%
Total Debt878K47K1,868%
FUNDAMENTALS RATINGS
ARTL vs LSTA: Fundamental Ratings
ARTL
LSTA
OUTLOOK RATING
1..100
5556
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4881
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (19) in the null industry is somewhat better than the same rating for ARTL (61). This means that LSTA’s stock grew somewhat faster than ARTL’s over the last 12 months.

LSTA's Profit vs Risk Rating (100) in the null industry is in the same range as ARTL (100). This means that LSTA’s stock grew similarly to ARTL’s over the last 12 months.

LSTA's SMR Rating (98) in the null industry is in the same range as ARTL (100). This means that LSTA’s stock grew similarly to ARTL’s over the last 12 months.

ARTL's Price Growth Rating (48) in the null industry is somewhat better than the same rating for LSTA (81). This means that ARTL’s stock grew somewhat faster than LSTA’s over the last 12 months.

ARTL's P/E Growth Rating (100) in the null industry is in the same range as LSTA (100). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLLSTA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEON57.851.58
+2.80%
VEON Ltd
KOS1.720.04
+2.38%
Kosmos Energy Ltd
CSGP89.101.24
+1.41%
CoStar Group
NISN3.59-0.16
-4.21%
NiSun International Enterprise Development Group Co Ltd
IRWD1.10-0.14
-11.29%
Ironwood Pharmaceuticals

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with PALI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then PALI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
-50.34%
PALI - ARTL
34%
Loosely correlated
-2.41%
CRMD - ARTL
32%
Poorly correlated
-6.57%
FATE - ARTL
31%
Poorly correlated
-2.71%
LSTA - ARTL
29%
Poorly correlated
-8.26%
IGC - ARTL
29%
Poorly correlated
-6.81%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
-8.26%
RAIN - LSTA
29%
Poorly correlated
-8.45%
CRIS - LSTA
27%
Poorly correlated
-0.58%
LGVN - LSTA
27%
Poorly correlated
-8.31%
TPST - LSTA
26%
Poorly correlated
-4.48%
ASND - LSTA
26%
Poorly correlated
-0.94%
More